Improved prophylaxis of postoperative nausea vomiting: Palonosetron a novel antiemetic
- PMID: 25886096
- PMCID: PMC4173575
- DOI: 10.4103/0259-1162.128894
Improved prophylaxis of postoperative nausea vomiting: Palonosetron a novel antiemetic
Abstract
Many anti-emetics are used in clinical practice. Palonosetron hydrochloride is one of them. It is a novel, centrally acting antiemetic, and anti-nausea agent. This drug is an antagonist of serotonin receptor subtype 3 (5-HT3). This drug has longer duration of action which makes it useful in the prevention and treatment of acute and delayed onset of nausea and vomiting. This drug was initially used for chemotherapy induced nausea and vomiting. Federal drug agency (FDA) has approved it for prevention and treatment of post-operative nausea and vomiting. The literature search for this article was done using Google scholar and Pubmed using the terms "Palonosetron," "longer duration of action," "nausea," "vomiting," and "postoperative".
Keywords: 5-HT3; Antiemetics; anesthesia; nausea; palonosetron; post-operative; vomiting.
Conflict of interest statement
Figures
References
-
- Myles PS, Williams DL, Hendrata M, Anderson H, Weeks AM. Patient satisfaction after anesthesia and surgery: Results of a prospective survey of 10,811 patients. Br J Anaesth. 2000;84:6–10. - PubMed
-
- Macario A, Weinger M, Carney S, Kim A. Which clinical anesthesia outcomes are important to avoid? Anesth Analg. 1999;89:652–8. - PubMed
-
- Lee A, Gin T, Lau AS, Ng FF. A comparison of patients’ and health care professionals’ preferences for symptoms during immediate postoperative recovery and the management of postoperative nausea and vomiting. Anesth Analg. 2005;100:87–93. - PubMed
-
- Gan TJ. Postoperative nausea and vomiting: Can it be eliminated? JAMA. 2002;287:1233–6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources